<DOC>
	<DOCNO>NCT03087162</DOCNO>
	<brief_summary>New drug regimen Helicobacter pylorus eradication , investigator compare daily dose dexlansoprazole levofloxacin base quadruple therapy twice daily dose dexlansoprazole levofloxacin quadruple therapy helicobacter pylori eradication .</brief_summary>
	<brief_title>Once Daily Dose Dexlansoprazole Quadruple Therapy Helicobacter Pylori</brief_title>
	<detailed_description>Once daily dose dexlansoprazole non inferior twice daily dose eradication Helicobacter pylorus infection .</detailed_description>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>1 . Age 1875 yearpatient 2 . Diagnosed positive Helicobacter Pylori test follow method : Rapid urease test Histology 3 . Inform consent 1 . Previous history Helicobacter pylorus eradication 2 . Contraindications allergic reaction study drug 3 . Previous gastric surgery advance gastric cancer malignancy severe concurrent diseases 4 . Decompensated Liver cirrhosis chronic kidney disease ( GFR &lt; 30 ) 5 . Mental disorder alcohol drug addiction 6 . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>